(Q43085713)

13 November 2017

Factors influencing research drug trials in adolescents with anorexia nervosa (English)

1 reference

13 November 2017

0 references

1 reference

Mark L Norris

1

1 reference

13 November 2017

Wendy Spettigue

2

1 reference

13 November 2017

Annick Buchholz

3

1 reference

13 November 2017

Katherine A Henderson

4

1 reference

13 November 2017

Nicole Obeid

5

1 reference

13 November 2017

1 May 2010

1 reference

13 November 2017

1 reference

13 November 2017

18

1 reference

13 November 2017

3

1 reference

13 November 2017

210-217

1 reference

Report of the National Institutes of Health workshop on overcoming barriers to treatment research in anorexia nervosa

13 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Lifetime course of eating disorders: design and validity testing of a new strategy to define the eating disorders phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Classification of child and adolescent eating disturbances. Workgroup for Classification of Eating Disorders in Children and Adolescents (WCEDCA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Motivation to change in eating disorders: clinical and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Eating disorders: National Institute of Mental Health's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Recruitment for an adolescent bulimia nervosa treatment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Olanzapine: review of safety 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Participant recruitment for an anorexia nervosa treatment study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Excess mortality, causes of death and prognostic factors in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Outcome of eating disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

Testing the validity of eating disorder diagnoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10640261003719468

10.1080/10640261003719468

21 January 2018

Identifiers

DOI

1 reference

13 November 2017

1 reference